Cardiopulmonary Exercise Testing Market: Global Industry Trends, Growth and Forecast
The Cardiopulmonary Exercise Testing Market is expanding steadily as healthcare providers increasingly focus on accurate assessment of cardiovascular and pulmonary performance. According to Market Research Future, the market was valued at USD 0.96 billion in 2024 and is projected to grow from USD 1.03 billion in 2025 to approximately USD 2.09 billion by 2035, registering a CAGR of 7.33% during the forecast period.
Cardiopulmonary exercise testing plays an important role in evaluating exercise capacity, identifying cardiovascular and respiratory limitations, and supporting treatment planning. Rising cardiovascular and chronic respiratory diseases are increasing the need for reliable diagnostic technologies. Growing awareness of preventive healthcare and exercise physiology is also contributing to market expansion.
The market is segmented by product into CPET metabolic carts and software, while end users include hospitals and clinics, diagnostic centers, ambulatory centers, and others. CPET metabolic carts currently represent the dominant product segment, whereas software is gaining momentum because of advanced data analysis and digital healthcare integration.
North America remains a leading regional market due to advanced healthcare infrastructure and high adoption of diagnostic technologies. Asia-Pacific is expected to grow rapidly as healthcare investment and awareness increase.
Technological innovation, personalized healthcare, artificial intelligence, portable testing systems, and telehealth integration are expected to create new opportunities for market participants through 2035.